Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000146

Chief Legal Officer sold 4,182 shares at $24.31 ($101,644)

  • Chief Legal Officer acquired 7,674 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-30 Exercise or conversion : show line 1 in the form +1,924 26,516 D
2024-10-30 Exercise or conversion : show line 2 in the form +2,000 28,516 D
2024-10-30 Exercise or conversion : show line 3 in the form +3,750 32,266 D
2024-10-30 Sale : show line 4 in the form −4,182 $24.31 $101,644 28,084 D
Open-market sales · 4,182 sh · avg $24.31 · $101,644

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-10-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −1,924 9,621 D
2024-10-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,000 12,000 D
2024-10-30 Exercise or conversion : show line 7 in the form Restricted Stock Units −3,750 37,500 D
Loading xslF345X05/wk-form4_1730334601.xml…